Skip to main content
News Icon

News categories: Honors & Funding

Cluster member among highly cited researcher

Annually the 'Highly Cited Researchers' are being announced by the 'Web of Science Group'.

At the University of Bonn 12 highly cited researcher are namend, among them are 6 members of the cluster of excellence ImmunoSensation.

According to the makers of the ranking, the people on this list of "Highly Cited Researchers" are among the most influential one percent of their subject. The measurement here is the frequency with which their scientific publications have been cited by other researchers in the past decade (period from 2008 to 2018). The ranking is published annually by the "Web of Science Group" and contains around 6,200 scientists in 21 subject categories.

Following members of ImmunoSensation2 are named 'Highly Cited Researcher':

Monique M. B. Breteler

Michael T. Heneka

Eicke Latz

Mihai G. Netea

Joachim L. Schultze

Andreas Schlitzer

Related news

News Icon

News categories: Honors & Funding

Otto-Westphal Thesis Prize for Jonas Schulte-Schrepping

The German Society for Immunology e.V. (DGfI) anually honours one of its members by awarding the Otto-Westphal Thesis Prize. This year, Jonas Schulte-Schrepping from the research group of Prof. Joachim Schultze at the DZNE was selected for his PhD thesis on the systemic immune response to COVID-19. The prize is endowed with a prize money of 1,500 EUR.
View entry
DGORH Honours

News categories: Honors & Funding

Honours for research orthopaedic rheumatology

The German Society for Orthopaedic Rheumatology (DGORh) awards the Arthur Vick Prize annually. The award serves to promote research in the field of orthopaedic rheumatology. The prize is endowed with 7,000 euros.
View entry
News Icon

News categories: Honors & Funding

Acute lymphoblastic leukemia in children

Acute lymphoblastic leukemia (ALL) is the most common cancer in children and poses a significant threat to health. The joint research project "EDI-4-ALL" (Early detection and interception for acute lymphoblastic leukemia) aims at the development of new analysis tools for the early detection of a genetic predisposition to ALL in newborns. The project is a joint endeavour by leading scientists from the Universities of Düsseldorf, Gießen and Bonn, the Charité Berlin and Zytovision, under participation of Prof. Alksandra Pandyra. The project is funded with a total of 2.6 million Euros by the BMBF.
View entry

Back to the news overview